SCHEMBL6680191

SCHEMBL6680191

Cc1cc(-c2ccccc2)c(C(=O)Nc2ccc(OCCc3csc(NC(=O)OC(C)(C)C)n3)cc2)cc1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
USP2 O75604 1/20 0.38
USP8 P40818 1/20 0.38
MAPT P10636 5/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37
HTT P42858 1/20 0.37
S1PR1 P21453 3/20 0.37
S1PR3 Q99500 2/20 0.37
SCD O00767 1/20 0.36
SREBF2 Q12772 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
POLB P06746 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6501138 0.88 MAPT (0.44) LMNASMN1; SMN2KDM4EMAPTHTT
SCHEMBL6789164 0.84 TP53 (0.45) LMNASMN1; SMN2KDM4EMAPTPOLB
SCHEMBL6490959 0.83 TP53 (0.43) LMNAMAPTSREBF2NPC1RAB9A
SCHEMBL6677053 0.80 ITGB1 (0.44) MAPTS1PR1S1PR3POLB
SCHEMBL6648515 0.78 LMNA (0.42) LMNASMN1; SMN2KDM4EMAPTMEN1
SCHEMBL7079416 0.78 MAPT (0.44) LMNASMN1; SMN2KDM4EUSP2USP8
SCHEMBL6677401 0.77 SORT1 (0.39) S1PR1S1PR3RXFP1
SCHEMBL6646880 0.76 RXFP1 (0.37) SMN1; SMN2MAPTSREBF2NPC1RAB9A
SCHEMBL6492199 0.76 TP53 (0.46) LMNAKDM4EUSP2USP8MAPT
SCHEMBL2656935 0.75 RAB9A (0.51) LMNASMN1; SMN2KDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1472226-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-03 EP disclosed
WO-2003045921-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-05 WO disclosed